Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 324,800 shares, a decline of 22.0% from the April 30th total of 416,400 shares. Based on an average daily volume of 671,600 shares, the […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) – Equities research analysts at Litchfield Hills Research upped their Q2 2023 earnings per share estimates for Adial Pharmaceuticals in a report released on Thursday, May 18th. Litchfield Hills Research analyst T. O’neill now expects that the company will post earnings of ($0.09) per share for the quarter, […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 416,400 shares, an increase of 42.6% from the April 15th total of 292,100 shares. Based on an average trading volume of 682,600 shares, the […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) – Equities research analysts at Litchfield Hills Research issued their FY2023 EPS estimates for Adial Pharmaceuticals in a report released on Monday, April 3rd. Litchfield Hills Research analyst T. O’neill anticipates that the company will earn ($0.49) per share for the year. The consensus estimate for Adial Pharmaceuticals’ […]